P21WAF1/CIP1 deficiency induces mitochondrial dysfunction in HCT116 colon cancer cells

Biochemical and Biophysical Research Communications

Volumn 430, Issue 2, 2013, Pages 653-658

  Kim, Ae Jeong ^a   Jee, Hye Jin ^a   Song, Naree ^a   Kim, Minjee ^a   Jeong, Seon Young ^a,b   Yun, Jeanho ^a  

^a Dong A University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

AMPK; Mitochondria; P21; PGC 1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; GALACTOSE; MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; AMP ACTIVATED PROTEIN KINASE KINASE; AMP-ACTIVATED PROTEIN KINASE KINASE; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PROTEIN KINASE; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BIOGENESIS; CANCER CELL CULTURE; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA CONTENT; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION; PRIORITY JOURNAL; PROTEIN DEPLETION; STEADY STATE; WILD TYPE; CELL STRAIN HCT116; GENETICS; METABOLISM; MITOCHONDRIAL DYNAMICS; MITOCHONDRION; NEOPLASM;

CYCLIN-DEPENDENT KINASE INHIBITOR P21; HCT116 CELLS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL TURNOVER; NEOPLASMS; PROTEIN KINASES; TUMOR SUPPRESSOR PROTEINS;

MLCS; MLOWN;

EID: 84872347549     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.096     Document Type: Article

References (30)

1. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 75:805-816.
2. Morgan D.O. Principles of CDK regulation. Nature 1995, 374:131-134.
3. Cazzalini O., Scovassi A.I., Savio M., Stivala L.A., Prosperi E. Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat. Res. 2010, 704:12-20.
4. Abbas T., Dutta A. p21 in cancer: intricate networks and multiple activities. Nat. Rev. Cancer 2009, 9:400-414.
5. Mahyar-Roemer M., Roemer K. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene 2001, 20:3387-3398.
6. Roninson I.B. Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett. 2002, 179:1-14.
7. Gartel A.L. The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosis. Leuk. Res. 2005, 29:1237-1238.
8. Umar A., Buermeyer A.B., Simon J.A., Thomas D.C., Clark A.B., Liskay R.M., Kunkel T.A. Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis. Cell 1996, 87:65-73.
9. De la Cueva E., Garcia-Cao I., Herranz M., Lopez P., Garcia-Palencia P., Flores J.M., Serrano M., Fernandez-Piqueras J., Martin-Caballero J. Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma. Oncogene 2006, 25:4128-4132.
10. Shen K.C., Heng H., Wang Y., Lu S., Liu G., Deng C.X., Brooks S.C., Wang Y.A. ATM and p21 cooperate to suppress aneuploidy and subsequent tumor development. Cancer Res. 2005, 65:8747-8753.
11. Topley G.I., Okuyama R., Gonzales J.G., Conti C., Dotto G.P. P21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential. Proc. Natl. Acad. Sci. USA 1999, 96:9089-9094.
12. Taylor R.W., Turnbull D.M. Mitochondrial DNA mutations in human disease. Nat. Rev. Genet. 2005, 6:389-402.
13. Zeviani M., Carelli V. Mitochondrial disorders. Curr. Opin. Neurol. 2003, 16:585-594.
14. Kang D., Hamasaki N. Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes, and cancer. Curr. Med. Chem. 2005, 12:429-441.
15. Kim H.J., Roh M.S., Son C.H., Kim A.J., Jee H.J., Song N., Kim M., Seo S.Y., Yoo Y.H., Yun J. Loss of Med1/TRAP220 promotes the invasion and metastasis of human non-small-cell lung cancer cells by modulating the expression of metastasis-related genes. Cancer Lett. 2012, 321:195-202.
16. Kim M.A., Kim H.J., Brown A.L., Lee M.Y., Bae Y.S., Park J.I., Kwak J.Y., Chung J.H., Yun J. Identification of novel substrates for human checkpoint kinase Chk1 and Chk2 through genome-wide screening using a consensus Chk phosphorylation motif. Exp. Mol. Med. 2007, 39:205-212.
17. Maftah A., Petit J.M., Ratinaud M.H., Julien R. 10-N nonyl-acridine orange: a fluorescent probe which stains mitochondria independently of their energetic state. Biochem. Biophys. Res. Commun. 1989, 164:185-190.
18. Kelly D.P., Scarpulla R.C. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 2004, 18:357-368.
19. Kanki T., Ohgaki K., Gaspari M., Gustafsson C.M., Fukuoh A., Sasaki N., Hamasaki N., Kang D. Architectural role of mitochondrial transcription factor A in maintenance of human mitochondrial DNA. Mol. Cell. Biol. 2004, 24:9823-9834.
20. Zong H., Ren J.M., Young L.H., Pypaert M., Mu J., Birnbaum M.J., Shulman G.I. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci. USA 2002, 99:15983-15987.
21. Nisoli E., Clementi E., Paolucci C., Cozzi V., Tonello C., Sciorati C., Bracale R., Valerio A., Francolini M., Moncada S., Carruba M.O. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003, 299:896-899.
22. Nisoli E., Falcone S., Tonello C., Cozzi V., Palomba L., Fiorani M., Pisconti A., Brunelli S., Cardile A., Francolini M., Cantoni O., Carruba M.O., Moncada S., Clementi E. Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc. Natl. Acad. Sci. USA 2004, 101:16507-16512.
23. Aguer C., Gambarotta D., Mailloux R.J., Moffat C., Dent R., McPherson R., Harper M.E. Galactose enhances oxidative metabolism and reveals mitochondrial dysfunction in human primary muscle cells. PLoS ONE 2011, 6:e28536.
24. Marroquin L.D., Hynes J., Dykens J.A., Jamieson J.D., Will Y. Circumventing the crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. Toxicol. Sci. 2007, 97:539-547.
25. Delavaine L., La Thangue N.B. Control of E2F activity by p21Waf1/Cip1. Oncogene 1999, 18:5381-5392.
26. Coqueret O., Gascan H. Functional interaction of STAT3 transcription factor with the cell cycle inhibitor p21WAF1/CIP1/SDI1. J. Biol. Chem. 2000, 275:18794-18800.
27. Fritah A., Saucier C., Mester J., Redeuilh G., Sabbah M. P21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha. Mol. Cell. Biol. 2005, 25:2419-2430.
28. Redeuilh G., Attia A., Mester J., Sabbah M. Transcriptional activation by the oestrogen receptor alpha is modulated through inhibition of cyclin-dependent kinases. Oncogene 2002, 21:5773-5782.
29. Devgan V., Mammucari C., Millar S.E., Brisken C., Dotto G.P. P21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. Genes. Dev. 2005, 19:1485-1495.
30. Valentin-Vega Y.A., Kastan M.B. A new role for ATM: regulating mitochondrial function and mitophagy. Autophagy 2012, 8:840-841.